Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Turetsky, B. I. Articles by Moberg, P. J. Search for Related Content PubMed Citation Articles by Turetsky, B. I. Articles by Moberg, P. J. Schizophrenia Spectrum Disorders Genetics Related Article

An Odor-Specific Threshold Deficit Implicates Abnormal Intracellular Cyclic AMP Signaling in Schizophrenia

OBJECTIVE: Although olfactory deficits are common in schizophrenia, their underlying pathophysiology remains unknown. Recent evidence has suggested that cAMP signaling may be disrupted in schizophrenia. Since cAMP mediates signal transduction in olfactory receptor neurons, this could contribute to the etiology of observed olfactory deficits. This study was designed to test this hypothesis by determining odor detection threshold sensitivities to two odorants that differ in their relative activations of this intracellular cAMP signaling cascade. METHOD: Thirty schizophrenia patients, 25 healthy comparison subjects, and 19 unaffected first-degree relatives of schizophrenia patients were studied. Odor detection threshold sensitivities were measured for the two odorants citralva and lyral. Although both have fruity/floral scents, citralva strongly activates adenylyl cyclase to increase cAMP levels, while lyral is a very weak activator of adenylyl cyclase. RESULTS: There was a significant group-by-odor interaction. Both schizophrenia patients and unaffected first-degree relatives were impaired in their ability to detect lyral versus citralva. Comparison subjects were equally sensitive to both odorants. This selective deficit could not be explained by differences in age, sex, smoking, clinical symptom profile, or medication use. CONCLUSIONS: This study establishes the presence of an odor-specific hyposmia that may denote a disruption of cAMP-mediated signal transduction in schizophrenia. The presence of a parallel deficit in the patients’ unaffected first-degree relatives suggests that this deficit is genetically mediated. Although additional physiological studies are needed to confirm the underlying mechanism, these results offer strong inferential support for the hypothesis that cAMP signaling is dysregulated in schizophrenia.

Related Article:

In This Issue
Am J Psychiatry 2009 166: A18. [Full Text] [PDF]

This article has been cited by other articles:

				B. I. Turetsky, C.-G. Hahn, K. Borgmann-Winter, and P. J. Moberg Scents and Nonsense: Olfactory Dysfunction in Schizophrenia Schizophr Bull, November 1, 2009; 35(6): 1117 - 1131. [Abstract] [Full Text] [PDF]

				M. J. SERBY Odor Detection in Schizophrenia: Alternative Explanations Am J Psychiatry, June 1, 2009; 166(6): 727 - 728. [Full Text] [PDF]

				Something's Not So Smelly in Schizophrenia Journal Watch Psychiatry, March 16, 2009; 2009(316): 5 - 5. [Full Text]

				A. Sawa and N. G. Cascella Peripheral Olfactory System for Clinical and Basic Psychiatry: A Promising Entry Point to the Mystery of Brain Mechanism and Biomarker Identification in Schizophrenia Am J Psychiatry, February 1, 2009; 166(2): 137 - 139. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2009 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us